IDEXX Laboratories Inc. logo

IDEXX Laboratories Inc.

IDXX | NASDAQ
Chart Builder DCF Calculator
$516.38
+$4.73 (+0.92%)
Sep 21, 2026, 12:01 PM ET · Market open
+0.92%

Rating

Updated: Sep 8, 2026
69.7
Fundamentals Excellent
Market Sentiment Neutral
Moat Wide

Key Statistics

Market Data

Market Cap $40.73B
1D Range
506.22 516.61
52W Range
500.61 769.98

Valuation (TTM)

PE 36.24
PB 25.03
EV/EBITDA 26.09

Valuation (NTM)

Forward PE 29.92
Forward PEG 2.65
Price Target $665
Loading financial charts...

Profile

IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary pra...

Sector Healthcare
Employees 11,000
IPO Date Jun 20, 1991
Fiscal Year January - December

Latest News

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets

10 hours ago · defenseworld.net

IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference

10 hours ago · defenseworld.net

IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference
IDEXX Stock Gains Following the Acquisition of CoVet

4 days ago · zacks.com

IDEXX Stock Gains Following the Acquisition of CoVet
IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection

4 days ago · businesswire.com

IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence

5 days ago · businesswire.com

IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

7 days ago · seekingalpha.com

IDEXX Laboratories, Inc. (IDXX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock

11 days ago · fool.com

Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock
Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?

18 days ago · zacks.com

Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

21 days ago · gurufocus.com

IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
Idexx Laboratories (IDXX) is a Top-Ranked Growth Stock: Should You Buy?

21 days ago · zacks.com

Idexx Laboratories (IDXX) is a Top-Ranked Growth Stock: Should You Buy?

Earnings

Next Earnings
Nov 2, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
8
Consensus
Buy
Price Target
$665
Upside
+28.78%
Buy (5)
Hold (3)
Sell (0)
Analyst Details

© 2026 bestshares.com. All rights reserved.